Bevacizumab in vitreous haemorrhage secondary to radiation retinopathy

BMJ Case Reports

Volumn , Issue , 2014, Pages

  Montero, Javier Antonio ^a   Yanez Castro, Giovanni ^a   Sanchis Merino, Maria Eugenia ^a   Ruiz Moreno, Jose Maria ^b  

^a HOSPITAL UNIVERSITARIO RÍO HORTEGA   (Spain)

^b UNIVERSITY OF CASTILLA LA MANCHA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ACETAZOLAMIDE; BEVACIZUMAB; DEXAMETHASONE; DICLOFENAC; LEVOBUNOLOL; TRIAMCINOLONE;

ADULT; ARTICLE; CAPSULOTOMY; CASE REPORT; CLINICAL FEATURE; ESTHESIONEUROBLASTOMA; EXTERNAL BEAM CRANIAL IRRADIATION; EXTERNAL BEAM RADIOTHERAPY; EYE DISCOMFORT; EYE DISEASE; FLUORESCENCE ANGIOGRAPHY; HUMAN; LENS IMPLANTATION; MALE; OPHTHALMIC NEODYMIUM YAG LASER; OPTICAL COHERENCE TOMOGRAPHY; PERIPAPILLARY COTTON WOOL SPOT; PHACOEMULSIFICATION; PRIORITY JOURNAL; RADIATION INJURY; RETINA DETACHMENT; RETINA EDEMA; RETINA HEMORRHAGE; RETINA ISCHEMIA; RETINA RADIATION TRAUMA; RETINOPATHY; SUBCAPSULAR CATARACT; SUBRETINAL NEOVASCULARIZATION; TREATMENT FAILURE; VITRECTOMY; VITREOUS HEMORRHAGE;

EID: 84896727388     PISSN: None     EISSN: 1757790X     Source Type: Journal    
DOI: 10.1136/bcr-2013-203177     Document Type: Article

References (20)

1. Brown GC, Shields JA, Sanborn G, et al. Radiation retinopathy. Ophthalmology 1982;89:1494-501. (Pubitemid 13217693)
2. Giuliari GP, Sadaka A, Hinkle DM, et al. Current treatments for radiation retinopathy. Acta Oncol 2011;50:6-13.
3. Wen JC, McCannel TA. Treatment of radiation retinopathy following plaque brachytherapy for choroidal melanoma. Curr Opin Ophthalmol 2009;20:200-4.
4. Shields CL, Demirci H, Dai V, et al. Intravitreal triamcinolone acetonide for radiation maculopathy after plaque radiotherapy for choroidal melanoma. Retina 2005;25:868-74. (Pubitemid 41456578)
5. Horgan N, Shields CL, Mashayekhi A, et al. Periocular triamcinolone for prevention of macular edema after iodine 125 plaque radiotherapy of uveal melanoma. Retina 2008;28:987-95.
6. Kuppermann BD, Thomas EL, de Smet MD, et al. Pooled efficacy results from two multinational randomized controlled clinical trials of a single intravitreous injection of highly purified ovine hyaluronidase (Vitrase) for the management of vitreous hemorrhage. Am J Ophthalmol 2005;140:573-84. (Pubitemid 41455296)
7. Parsons JT, Bova FJ, Fitzgerald CR, et al. Radiation retinopathy after external-beam irradiation: analysis of time-dose factors. Int J Radiat Oncol Biol Phys 1994;30:765-73. (Pubitemid 24355923)
8. Aiello LP. Clinical implications of vascular growth factors in proliferative retinopathies. Curr Opin Ophthalmol 1997;8:19-31. (Pubitemid 27344615)
9. Finger PT. Radiation retinopathy is treatable with anti-vascular endothelial growth factor bevacizumab (Avastin). Int J Radiat Oncol Biol Phys 2008;70:974-7. (Pubitemid 351296131)
10. Vasquez LM, Somani S, Altomare F, et al. Intracameral bevacizumab in the treatment of neovascular glaucoma and exudative retinal detachment after brachytherapy in choroidal melanoma. Can J Ophthalmol 2009;44:106-7.
11. Querques G, Prascina F, Iaculli C, et al. Intravitreal pegaptanib sodium (Macugen) for radiation retinopathy following episcleral plaque radiotherapy. Acta Ophthalmol 2008;86:700-1.
12. Dunavoelgyi R, Zehetmayer M, Simader CS, et al. Rapid improvement of radiation-induced neovascular glaucoma and exudative retinal detachment after a single intravitreal ranibizumab injection. Clin Exp Ophthalmol 2007;35:878-80.
13. Tu KL, Kaye SB, Sidaras G, et al. Effect of intraocular surgery and ketamine on aqueous and serum cytokines. Mol Vis 2007;13:1130-7. (Pubitemid 47073980)
14. Patel JI, Hykin PG, Cree IA. Diabetic cataract removal: postoperative progression of maculopathy?growth factor and clinical analysis. Br J Ophthalmol 2006;90:697-701. (Pubitemid 43835483)
15. Bianciotto C, Shields CL, Pirondini C, et al. Vitreous hemorrhage after plaque radiotherapy for uveal melanoma. Retina 2012;32:1156-64.
16. Kinyoun JL, Chittum ME, Wells CG. Photocoagulation treatment of radiation retinopathy. Am J Ophthalmol 1988;105:470-8.
17. Ruiz-Moreno JM, Montero JA, Lugo F, et al. Intravitreal bevacizumab in recurrent diabetic vitreous haemorrhage after vitrectomy. Acta Ophthalmol 2008;86:231-2.
18. Yeh PT, Yang CH, Yang CM. Intravitreal bevacizumab injection for recurrent vitreous haemorrhage after diabetic vitrectomy. Acta Ophthalmol 2011;89:634-40.
19. Sawa H, Ikeda T, Matsumoto Y, et al. [Neovascularization from the scleral wound as the cause of vitreous rebleeding after vitrectomy for proliferative diabetic retinopathy]. Nihon Ganka Gakkai Zasshi 1998;102:200-6. (Pubitemid 28152505)
20. Miyke T, Sawada O, Kakinoki M, et al. Pharmacokinetics of bevacizumab and its effect on vascular endothelial growth factor after intravitreal injection of bevacizumab in macaque eyes. Invest Ophthalmol Vis Sci 2010;51:1606-8.